Biotechs in general, A few of the buyouts have not produced sales expected. Wall Street pumps the good, the bad and the ugly.
Look at the market cap of PCRX. Talk to doctors who have tried it and the sales figures that give you and idea of what sales figures will ever look like. Disillusioned biotech investors are throwing out the good the bad and the ugly. Looking for babies in that bathwater and hope to make some long term investments. A quick bounce that would hold their prices is not what I'm expecting, yet. Gonna have to think long term and hold on to those babies in the bathwater.
Anyone have any idea what would signal a real bottom in this sector?